Article
J&J raises profit forecast amid COVID-19 vaccine sales
Rating:
0.0
Views:
115
Likes:
1
Library:
1
Johnson & Johnson raised its 2021 profit forecast after sales for its COVID-19 vaccine, a cancer treatment and other drugs helped the company soar above Wall Street's third-quarter earnings predictions.The company said it now expects its adjusted earnings for 2021 to fall between $9.22 and $9.82 per share, according to The Associated Press.The pharmaceutical company also narrowed its forecast for operational sales, which does not take the...
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value